Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2012
05/17/2012US20120122854 Carbocyclic Fused Cyclic Amines
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122839 Novel pyrrolidin-2-ones
05/17/2012US20120122837 Inhibitors of fatty acid binding protein
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122709 Libraries of 1-(sulfonyl)-n-phenylpyrrolidine-2-carboxamides for the identification of biological and pharmacological activity
05/17/2012US20120121727 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/17/2012US20120119171 Near-infrared absorbing dye, near-infrared absorptive film-forming composition, and near-infrared absorptive film
05/16/2012EP2453496A1 Organic electroluminescent element, novel compound, lighting device and display device
05/16/2012EP2452997A2 Compound for an organic photoelectric element, and an organic photoelectric element comprising the same
05/16/2012EP2452936A1 Compositions and methods for coupling a plurality of compounds to a scaffold
05/16/2012EP2451804A1 Pyridazine compounds for controlling invertebrate pests
05/16/2012EP2451803A2 Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
05/16/2012EP2451802A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
05/16/2012EP2451800A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
05/16/2012EP2451795A1 Compositions and methods for enhancing virus efficacy
05/16/2012EP2451792A2 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines
05/16/2012EP2451790A1 Histone deacetylase inhibitors
05/16/2012EP2451782A1 Dual-acting pyrazole antihypertensive agents
05/16/2012EP2451285A1 Platelet-activating factor receptor antagonists
05/16/2012EP1864665B1 Immunosuppressive agent comprising a heterocyclic compound as active ingredient
05/16/2012CN1931827B 2- and 2,5-substituted phenylketo-enols
05/16/2012CN1854128B Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
05/16/2012CN102459411A New process and new compounds
05/16/2012CN102459271A 回折模拟物的新化合物及其制备方法和用途 Fold back the new compound mimics its preparation method and use
05/16/2012CN102459270A Janus激酶3的哌啶抑制剂 Janus kinase 3 inhibitor piperidine
05/16/2012CN102459265A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459250A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
05/16/2012CN102459239A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
05/16/2012CN102459238A 2,3-二氢-1h-茚化合物及其治疗癌症的用途 2,3-dihydro--1h- indene compounds and their use in the treatment of cancer
05/16/2012CN102459237A 6-(1h-咪唑-1-基)-2-苯基喹唑啉的晶型 6- (1h- imidazol-1-yl) -2-phenyl quinazoline crystalline form
05/16/2012CN102459236A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459235A 吡嗪基吡唑 Pyrazinyl pyrazole
05/16/2012CN102459234A 作为p70s6激酶抑制剂的取代的苯并三嗪类和喹喔啉类 As the substituted benzo triazines and quinoxaline p70s6 kinase inhibitor
05/16/2012CN102459230A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459229A 用作食欲肽拮抗剂的3-氮杂二环[4.1.0]庚烷 Orexin antagonists used azabicyclo [4.1.0] heptane
05/16/2012CN102459228A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459227A Ccr2的4-氮杂环丁烷基-1-苯基-环己烷拮抗剂 Ccr2 4-azetidinyl-1-phenyl - cyclohexane antagonist
05/16/2012CN102459226A Ccr2的4-氮杂环丁烷基-1-杂原子连接的-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroatom attached - cyclohexane antagonist
05/16/2012CN102459225A Ccr2的4-氮杂环丁烷基-1-杂芳基-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroaryl - cyclohexane antagonist
05/16/2012CN102459207A 环戊二烯并[c]吡咯-2-甲酸酯衍生物、其制备及其治疗用途 Cyclopenta [c] pyrrole-2-carboxylic acid ester derivatives, their preparation and their therapeutic use
05/16/2012CN102459178A 2,5-disubstituted arylsulfonamide ccr3 antagonists
05/16/2012CN102459172A 四环化合物 Tetracyclic compounds
05/16/2012CN102459167A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459166A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459165A 抗病毒化合物 Antiviral compounds
05/16/2012CN102452989A Aniline substituted quinazoline derivative
05/16/2012CN102452988A Quinazoline derivative and preparation method thereof
05/16/2012CN102452974A Organic light-emitting device
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178672 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 MAP kinase
05/15/2012US8178671 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178553 Compounds for the treatment of inflammatory disorders
05/15/2012US8178549 Azabicyclo [3. 1. O] hexyl derivatives as modulators of dopamine D3 receptors
05/15/2012US8178546 Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
05/15/2012US8178540 Pyrimidylmethyl-sulfonamide compounds
05/15/2012US8178538 Pyridazinones
05/15/2012CA2643005C Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof
05/15/2012CA2520714C Process for manufacture of telmisartan
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2430978C Vla-4 inhibitors
05/10/2012WO2012061696A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors
05/10/2012WO2012061576A1 Crystalline forms of ( s ) - 2 - amino - 3 - (4 - ( 2 - amino - 6 - ( (r) - 1 - (4 - ch loro-2- (3 -methyl- 1h- pyrazol- 1 -yl) phenyl) - 2, 2, 2 - trifluoroethoxy) pyrimidin- 4 - yl) phenyl) propanoic acid
05/10/2012WO2012061552A1 Novel inhibitors of hepatitis c virus
05/10/2012WO2012061415A1 Oxypyrimidines as syk modulators
05/10/2012WO2012061248A2 Novel specific hcv ns3 protease inhibitors
05/10/2012WO2012060738A1 CLATHRATE COMPLEXES OF β-CYCLODEXTRIN WITH 1-{[6-BROMO-1-METHYL-5-METHOXY-2-PHENYLTHIOMETHYL-1-H-INDOLE-3-YL]CARBONYL}-4-BENZYLPIPERAZINE HAVING ANTIVIRAL ACTIVITY, THE PRODUCTION AND USE THEREOF
05/10/2012WO2012059941A1 Process for preparation of sunitinib malate and salts thereof
05/10/2012WO2012059932A1 2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
05/10/2012WO2012059776A1 Indole derivatives
05/10/2012WO2012059507A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012WO2012059497A1 N-hetarylmethyl pyrazolylcarboxamides
05/10/2012WO2012058780A1 Processes for the preparation of 3-(pyrrol-2-yl)methylene)-2-pyrrolones using 2-silyloxy-pyrroles
05/10/2012WO2012019427A8 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
05/10/2012WO2012019426A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012WO2012017021A3 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
05/10/2012US20120116093 One pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
05/10/2012US20120115922 Smac mimetec
05/10/2012US20120115918 Anti-Viral Compounds
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115881 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115869 Tetrazole derivatives
05/10/2012US20120115866 Kinase inhibitor compounds
05/10/2012US20120115861 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/10/2012US20120115856 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
05/10/2012US20120115855 Inhibitors of hcv ns5a
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115843 Novel pyrrolidine derivatives
05/10/2012US20120115842 Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115819 Pentacycline Compounds
05/10/2012US20120115817 Phthalimide derivatives of non-steroidal anti-inflammatory compounds and/or tnf-alpha modulators, method for producing same, pharmaceutical compositions containing same and uses thereof for the treatment of inflammatory diseases
05/10/2012US20120115333 Polybenzoxazole precursor, photosensitive resin composition using the same, and manufacturing method of semiconductor device
05/10/2012US20120115247 Drug monitoring assay
05/10/2012US20120114696 Small-molecule botulinum toxin inhibitors
05/10/2012US20120114600 Novel inhibitors of hepatitis c virus
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 626